SAI LIFE SCIENCES LIMITED Share Price

SAI LIFE SCIENCES LIMITED Share Price

NSE: SAILIFE
|
Pharmaceuticals

₹ 1,440.30

-₹22.00 (-1.5%)
1D
Last updated 14 Oct, 2026, 11:06 IST

SAI LIFE SCIENCES LIMITED Share Price Today

As of 14 Oct 2026, SAI LIFE SCIENCES LIMITED share price is ₹1,440.30. The stock opened at ₹1,456.50, compared to its previous close of ₹1,462.30. During today's trading session, SAI LIFE SCIENCES LIMITED share price moved in the range of ₹1,421.30 to ₹1,456.60, with an average price of ₹1,438.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹783.85 and a high of ₹1,697.00. On the performance front, SAI LIFE SCIENCES LIMITED share price has increased by 47.60% over the last six months and is up 68.43% on a year-on-year basis.


₹1,421.30
1.50% down today
₹1,456.60
1D LOW
1D HIGH

SAI LIFE SCIENCES LIMITED Returns Calculator

Volume
1,44,672
Average traded price
₹1,435.85
Last traded time
11:06:33 14 Oct
Last traded quantity
2

Circuit
L
H
₹1,169.90
₹1,754.70
52-week
L
H
₹783.85
₹1,697.00
Mkt Cap Cr
31,225.48

P/E
85.87

P/B
12.51

ROA
9.98%
ROE
14.05%

ROCE
18.23%

Quick Ratio
1.51

EV/EBITDA
45.35
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Sai Life has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Sai Life appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Sai Life earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,76,300.5082.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About SAI LIFE SCIENCES LIMITED

SAI LIFE SCIENCES LIMITED Share Price
ISIN
INE570L01029
Sector Market Cap
₹ 31,225.48 Cr

Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.

SAI LIFE SCIENCES LIMITED Financial Highlights

  • Revenue: SAI LIFE SCIENCES LIMITED reported revenue of ₹2,241.62 crore in FY26 vs ₹1,731.35 crore in FY25. It showed an increase of 29.47% on a yearly basis.
  • Operating Profit: SAI LIFE SCIENCES LIMITED reported an operating profit of ₹466.19 crore in FY26 vs ₹227.70 crore in FY25. It showed an increase of 104.74% on a year-on-year basis.
  • Net Profit: SAI LIFE SCIENCES LIMITED reported a net profit of ₹348.91 crore in FY26 vs ₹170.13 crore in FY25. It showed an increase of 105.08% on a yearly basis.

SAI LIFE SCIENCES LIMITED Quarterly Result Highlights

  • SAI LIFE SCIENCES LIMITED reported revenue of ₹557.83 crore in Jun 2026, compared with ₹617.66 crore in Mar 2026, representing a decrease of 9.69% on a quarter-on-quarter (QoQ) basis.
  • SAI LIFE SCIENCES LIMITED reported an operating profit of ₹97.97 crore in Jun 2026, compared with ₹139.23 crore in Mar 2026, representing a decrease of 29.63% on a quarter-on-quarter (QoQ) basis.
  • SAI LIFE SCIENCES LIMITED reported a profit of ₹73.29 crore in Jun 2026, compared with ₹104.24 crore in Mar 2026, reflecting a decrease of 29.69% on a QoQ basis.
  • The earnings per share (EPS) of SAI LIFE SCIENCES LIMITED stood at ₹16.43 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
34.50%
FII
19.91%
Other DII
2.76%
Retail and other
13.26%
Mutual funds
29.56%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202521.40%
Mar 202621.17%
Jun 202619.65%
Sep 202619.91%
1 day
-0.61%

1 week
-6.15%

1 month
-7.74%

1 year
+68.43%

3 years
+91.24%

5 years
+91.24%
Day
Open / Close
Change %
13 Oct 26
₹1,472.00 / ₹1,462.30
-0.61%

12 Oct 26
₹1,489.00 / ₹1,471.30
-1.12%

09 Oct 26
₹1,509.80 / ₹1,487.90
-1.18%

08 Oct 26
₹1,563.40 / ₹1,505.60
-3.60%
Show more

SAI LIFE SCIENCES LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,192.49₹1,694.57₹1,465.18₹1,217.14
Other Income₹49.13₹36.78₹29.09₹27.97
Total Revenue₹2,241.62₹1,731.35₹1,494.27₹1,245.11
Total Expenses₹1,767.43₹1,503.65₹1,385.04₹1,228.70
Profit Before Tax₹466.19₹227.70₹109.23₹16.41
Tax₹117.28₹57.57₹26.43₹6.42
Profit After Tax₹348.91₹170.13₹82.81₹9.99
EPS - Basic₹16.43₹8.83₹4.57₹0.55
EPS - Diluted₹16.43₹8.61₹4.53₹0.55

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹466.19₹227.70₹109.23₹16.41
Income before WC changes₹621.86₹466.77₹315.20₹188.56
Change in Assets-₹165.81-₹284.74-₹11.70₹5.13
Change in Liabilities₹92.02₹153.65-₹26.54₹29.80
Change in WC-₹73.80-₹131.09-₹38.24₹34.93
Cash flow from Operations₹509.13₹314.05₹263.09₹219.40
Cash flow from Investing-₹395.41-₹536.67-₹192.38-₹101.78
Cash flow from Financing-₹123.68₹301.43-₹95.30-₹200.65
Total Cash Flow-₹9.96₹78.81-₹24.59-₹83.03
Cash (Start of the year)₹91.05₹11.97₹35.53₹115.78
Cash (End of the year)₹81.91₹91.05₹11.97₹35.53

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,215.61₹1,655.46₹1,330.02₹1,222.70
Current Assets₹1,410.53₹1,504.51₹945.11₹963.95
Total Assets₹3,626.14₹3,159.98₹2,275.14₹2,186.65
Current Liabilities₹833.68₹732.49₹739.90₹758.85
Net Current Asset₹576.85₹772.02₹205.21₹205.10
Non-Current Liabilities₹308.77₹299.13₹560.09₹539.70
Equity Capital₹2,483.69₹2,128.35₹975.14₹888.09
Total Equity & Liabilities₹3,626.14₹3,159.98₹2,275.14₹2,186.65

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,153.23₹1,642.05₹1,418.68₹1,157.40
Other Income₹49.13₹37.34₹29.33₹27.96
Total Revenue₹2,202.36₹1,679.38₹1,448.01₹1,185.36
Total Expenses₹1,738.18₹1,447.67₹1,319.01₹1,152.68
Profit Before Tax₹456.17₹231.72₹129.01₹32.69
Tax₹114.69₹58.25₹33.77₹8.45
Profit After Tax₹341.48₹173.46₹95.23₹24.24
EPS - Basic₹16.27₹9.00₹5.26₹13.42
EPS - Diluted₹16.08₹8.78₹5.21₹13.29

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹456.17₹231.72₹129.01₹32.69
Income before WC changes₹590.66₹452.11₹315.04₹186.76
Change in Assets-₹161.84-₹267.98-₹27.51₹18.97
Change in Liabilities₹104.94₹167.70-₹23.39₹19.82
Change in WC-₹56.90-₹100.28-₹50.90₹38.79
Cash flow from Operations₹495.27₹330.35₹250.64₹221.47
Cash flow from Investing-₹392.71-₹564.71-₹190.05-₹111.23
Cash flow from Financing-₹109.23₹314.31-₹84.63-₹190.04
Total Cash Flow-₹6.67₹79.95-₹24.04-₹79.80
Cash (Start of the year)₹85.12₹5.17₹29.21₹109.01
Cash (End of the year)₹78.60₹85.12₹5.17₹29.21

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,203.69₹1,642.12₹1,288.75₹1,178.69
Current Assets₹1,399.13₹1,494.54₹951.17₹951.93
Total Assets₹3,602.82₹3,136.66₹2,239.92₹2,130.62
Current Liabilities₹842.26₹727.20₹723.24₹739.36
Net Current Asset₹556.87₹767.35₹227.93₹212.57
Non-Current Liabilities₹252.59₹242.00₹505.48₹478.53
Equity Capital₹2,507.97₹2,167.46₹1,011.20₹912.73
Total Equity & Liabilities₹3,602.82₹3,136.66₹2,239.92₹2,130.62
* All values are in INR Crore
Qty
Bid
13
1440.3
21
1440.2
1
1440.1
22
1440
20
1439.9
Ask
Qty
1441
36
1441.1
13
1441.2
198
1441.3
15
1441.4
23
Bid Total: 77
Ask Total: 285
Buy orders: 21%
Sell orders: 79%
Bearish
2
Neutral
4
Bullish
2
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
39.06
Neutral

ATR (14)
52.64
Neutral

STOCH(9,6)
21.8
Neutral

STOCH RSI (14)
0
Bullish

ADX(9)
25.45
Bearish

UO(9)
40.03
Neutral

ROC(12)
-8.31
Bearish

WillR(14)
-84.04
Bullish
Period
Simple value
Exponential vaue

5D
1497.78
1489.98

10D
1518.39
1513.76

20D
1549.94
1530.53

50D
1508.84
1487.87

100D
1365.52
1381.39
Volume trend — traded volume by day
14 Oct1L
13 Oct7L
12 Oct3L
9 Oct4L
8 Oct5L
7 Oct6L
Average4L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SAI LIFE SCIENCES LIMITED Share Price
SAI LIFE SCIENCES LIMITED
Pharmaceuticals
Add Stock
Add Another

SAI LIFE SCIENCES LIMITED Share Price FAQs












Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.